DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meetings22-06-2024
22-06-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Closure of Trading Window
Intimation regarding closure of Trading window21-06-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter Ending On June 30, 2024
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ending on June 30, 202421-06-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement21-06-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst meet/ Institutional Investor meetings19-06-2024
Dr Reddy's Laboratories, Warburg Pincus, EQT front-runners for BSV
New Delhi based Mankind Pharma too is in the fray, but it is taking a more conservative approach towards valuation18-06-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Instituional Investor Meet18-06-2024
DrReddy's Draws Analysts' Caution As Weak Global Macros Dent Outlook
If the current trends, even gRevlimid may not be able to mask the impact of weakness in the erosion of baseline product prices for Dr. Reddy's, Citi said.18-06-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares on exercise of Employee stock options14-06-2024